Literature DB >> 26767520

IGF-1 as an Important Endogenous Growth Factor for Recovery from Impaired Urethral Continence Function in Rats with Simulated Childbirth Injury.

Yasuhiro Sumino1, Satoru Yoshikawa2, Ken-Ichi Mori1, Hiromitsu Mimata3, Naoki Yoshimura4.   

Abstract

PURPOSE: We examined the functional role of endogenous IGF-1 (insulin-like growth factor-1) in the recovery phase of stress urinary incontinence induced by simulated childbirth trauma using an IGF-1 receptor inhibitor.
MATERIALS AND METHODS: Simulated birth trauma was induced by vaginal distension in female Sprague Dawley® rats. The IGF-1 receptor antagonist JB-1 (10 and 100 μg/kg per day) or vehicle was continuously delivered from 1 day before vaginal distension for 7 days using subcutaneous osmotic pumps. Seven, 14 and 21 days after vaginal distension the effect of JB-1 treatment was examined by functional analyses, including leak point and urethral baseline pressure, and urethral responses during passive increments in intravesical pressure, as well as molecular analyses in urethral tissues, including phosphorylation of Akt, apoptotic changes and peripheral nerve density using Western blot and immunohistochemistry.
RESULTS: On functional analyses vehicle treated rats with vaginal distension had significantly decreased leak point and urethral baseline pressure, and urethral responses at 7 days, which recovered to the normal level 14 and 21 days after vaginal distension. In the JB-1 treated vaginal distension group leak point and urethral baseline pressure, and urethral responses were still significantly reduced 21 days after vaginal distension. On molecular analyses JB-1 treatment increased apoptotic cells, induced a significant decrease in phosphorylated Akt and prolonged the decrease of peripheral nerve density in urethral tissues.
CONCLUSIONS: Suppression of endogenous IGF-1 activity delayed recovery from stress urinary incontinence induced by simulated childbirth trauma in rats. Thus, IGF-1 is likely to be an important endogenous mediator for functional recovery from childbirth related stress urinary incontinence. This suggests that IGF-1 could be an effective target for treating stress urinary incontinence in women.
Copyright © 2016 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apoptosis; insulin-like growth factor I; stress; urethra; urinary incontinence; vagina

Mesh:

Substances:

Year:  2016        PMID: 26767520     DOI: 10.1016/j.juro.2015.12.087

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Analysis of continence reflexes by dynamic urethral pressure recordings in a rat stress urinary incontinence model induced by multiple simulated birth traumas.

Authors:  Joonbeom Kwon; Takahisa Suzuki; Ei-Ichiro Takaoka; Nobutaka Shimizu; Takahiro Shimizu; Shun Takai; Satoru Yoshikawa; William C de Groat; Naoki Yoshimura
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

2.  Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke.

Authors:  Cellas A Hayes; M Noa Valcarcel-Ares; Nicole M Ashpole
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-24       Impact factor: 6.200

3.  Molecular Assessment of Neuroregenerative Response in the Pudendal Nerve: A Useful Tool in Regenerative Urology.

Authors:  Bradley C Gill; Dan Li Lin; Brian M Balog; Charuspong Dissaranan; Hai-Hong Jiang; Margot S Damaser
Journal:  SDRP J Biomed Eng       Date:  2016-02-05

4.  Endoplasmic reticulum stress contributes to the pathogenesis of stress urinary incontinence in postmenopausal women.

Authors:  Yong Zhou; Xiaoxia Liu; Wenjuan Li; Xiaoyan Sun; Zhenwei Xie
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

Review 5.  Molecular Processes in Stress Urinary Incontinence: A Systematic Review of Human and Animal Studies.

Authors:  Wilke M Post; Joanna Widomska; Hilde Grens; Marieke J H Coenen; Frank M J Martens; Dick A W Janssen; Joanna IntHout; Geert Poelmans; Egbert Oosterwijk; Kirsten B Kluivers
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.